Nasdaq
BGLC
BioNexus Gene Lab Corp
- Health Care
- Malaysia
- 1 day
- +2.6%
- 1 month
- −17.3%
- 1 year
- −72.1%
$1.58 · Mkt cap $3.82M
At the 6 Aug 2026 close
Nasdaq
BioNexus Gene Lab Corp
$1.58 · Mkt cap $3.82M
At the 6 Aug 2026 close
BioNexus Gene Lab Corp trades under the ticker BGLC on Nasdaq, in the Health Care sector (Medical Specialities). Its market capitalisation is $3.82M. The last closing price was $1.58, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −72.1%, and −17.3% over the past month. Returns are price returns and exclude dividends.
This page exists because BGLC is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.